“I Want My [Prescription-Drug] Money Back!”
[By Patrick C. Cox; Jr.]
Merck & Company may have to as a result of a recently filed lawsuit in the state of Florida.
Coming on the heels of the disappointing Vytorin™ Enhance Trial results, patient Marion J. Greene, 72, is suing to get her money back. She had been taking Vytorin™ at $100 a month instead of generic cholesterol medications at about one third the costs.
Apparently Ms. Greene feels she hasn’t been getting her money’s worth and claims Merck has misled the public. Although some of her costs were reimbursed, she is seeking a refund of what her attorneys are calling “overpayments.”
Class Action Lawsuit Status Sought
The lawsuit has been filed in Jacksonville and attorneys are seeking class-action status charging Merck & Co. with misleading patients about the effectiveness of Vytorin™.
State consumer protection laws, breach of warranty, and unjust enrichment law violations will form the basis of the charges that Merck overstated Vytorin’s effectiveness vs. generics.
Oversight
The lawsuit certainly will raise more public eyebrows and questions about drug company sales and marketing practices.
You can bet too that Congress will be looking into expanding its oversight as the public demands more accountability. With more awareness and scrutiny physicians cannot afford to be caught in the middle by continuing take drug company promotional claims at face value.
As things heat up MD/DO’s can count on being challenged even more to defend their choices of one medication over the other, or they too could be faced with a patient screaming, “I want my money back!”
Assessment
Has a patient ever cried foul like this to you; if so, what have you done?
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- DICTIONARIES: http://www.springerpub.com/Search/marcinko
- PHYSICIANS: www.MedicalBusinessAdvisors.com
- PRACTICES: www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: www.CertifiedMedicalPlanner.org
- BLOG: www.MedicalExecutivePost.com
- FINANCE:Financial Planning for Physicians and Advisors
- INSURANCE:Risk Management and Insurance Strategies for Physicians and Advisors
Filed under: Drugs and Pharma | Tagged: Big Pharma and Drugs | 3 Comments »













